← Mechanisms of action
TNFRSF10B
SINGLE PROTEINHomo sapiens
Preferred name: Tumor necrosis factor receptor superfamily member 10B ChEMBL ↗
Linked proteins
Drugs acting on this target (22)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| apomab | Agonist | experimental | mAb | TNFRSF10B agonist |
| conatumumab | Agonist | experimental | mAb | TNFRSF10B agonist |
| drozitumab | Agonist | experimental | mAb | TNFRSF10B agonist |
| dulanermin | Agonist | experimental | Peptide | TNFRSF10B agonist |
| lby-135 | Agonist | experimental | mAb | TNFRSF10B agonist |
| lexatumumab | Agonist | experimental | mAb | TNFRSF10B agonist |
| tigatuzumab | Agonist | experimental | mAb | TNFRSF10B agonist |
| htr2 t cells | Immunity, passive | experimental | Cell therapy | TNFRSF10B immunity, passive |
| 111in-cs-1008 | Inhibitor | experimental | mAb | TNFRSF10B inhibitor |
| apomab | Inhibitor | experimental | mAb | TNFRSF10B inhibitor |
| bi 905711 | Inhibitor | experimental | mAb | TNFRSF10B inhibitor |
| conatumumab | Inhibitor | experimental | mAb | TNFRSF10B inhibitor |
| dulanermin | Inhibitor | experimental | Peptide | TNFRSF10B inhibitor |
| gen1029 | Inhibitor | experimental | mAb | TNFRSF10B inhibitor |
| ibi3004 | Inhibitor | experimental | mAb | TNFRSF10B inhibitor |
| igm-8444 | Inhibitor | experimental | mAb | TNFRSF10B inhibitor |
| inbrx-109 | Inhibitor | experimental | mAb | TNFRSF10B inhibitor |
| lby-135 | Inhibitor | experimental | mAb | TNFRSF10B inhibitor |
| lexatumumab | Inhibitor | experimental | mAb | TNFRSF10B inhibitor |
| ro6874813 | Inhibitor | experimental | mAb | TNFRSF10B inhibitor |
| tas266 | Inhibitor | experimental | mAb | TNFRSF10B inhibitor |
| tigatuzumab | Inhibitor | experimental | mAb | TNFRSF10B inhibitor |